Veraxa Biotech AG (VRXAW) Warrant
Each VRXAW warrant gives the holder the right to buy 1 share of Veraxa Biotech AG at $11.50 per share, until June 10, 2031. The stock last closed at $1.13, below the strike, so the warrant is out of the money. Veraxa Biotech AG has a market value of about $159.79M. There are 12.65M listed warrants; exercising all of them would add 8.9% to the 141.41M shares outstanding. The company can call the warrants if the stock trades at or above $10.00.
VRXA vs strike, last 12 months
No share-price history for VRXA yet.
Key terms
- Strike per share
- $11.50
- Shares per warrant
- 1
- Cash to exercise one warrant
- $11.50
- Expiry
- 2031-06-10
- Redemption trigger
- $10.00
- Cashless exercise
- allowed
- Break-even stock price
- $11.54
From the issuer's 424B3 (2026-02-19).
Company and stock
- Company
- Veraxa Biotech AG
- Underlying stock
- VRXA
- Share price
- $1.13
- Market cap
- $159.79M
- Shares outstanding
- 141.41M
- Value of all listed warrants
- $459.19K (0.3% of market cap)
Market cap is the last share price times shares outstanding (as of 20-F 2026-). All SEC filings for this company.
Model value vs price Pro
- Model value
- Last price
- $0.0363
- Price / model
Get Pro to see whether VRXAW is cheap or rich against our model.
Dilution
- Shares outstanding
- 141.41M
- Listed warrants
- 12.65M
- Dilution if all exercised
- 8.9%
Warrant count from filing notes, read by hand (high): Public Warrants (former Voyager Acquisition Corp public warrants).
Filings and events
- Merger closed; the warrants became warrants of the combined company
- Terms source: 424B3
Questions about VRXAW
When does the VRXAW warrant expire?
VRXAW expires on June 10, 2031.
What is the strike price of VRXAW?
$11.50 per share; each warrant converts into 1 share, so exercising one warrant costs $11.50.
Can Veraxa Biotech AG redeem the VRXAW warrants early?
Yes. The company can call them if the share price reaches $10.00 for the required period (usually 20 of 30 trading days).
How many VRXAW warrants are outstanding?
12.65M listed warrants, equal to 8.9% dilution if all are exercised.